Zynex ROA 2010-2024 | ZYXI
Current and historical return on assets (ROA) values for Zynex (ZYXI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Zynex ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $0.00B | $0.13B | 3.13% |
| 2024-06-30 | $0.01B | $0.12B | 4.48% |
| 2024-03-31 | $0.01B | $0.13B | 5.64% |
| 2023-12-31 | $0.01B | $0.14B | 7.25% |
| 2023-09-30 | $0.02B | $0.15B | 12.05% |
| 2023-06-30 | $0.02B | $0.15B | 13.74% |
| 2023-03-31 | $0.02B | $0.11B | 14.72% |
| 2022-12-31 | $0.02B | $0.12B | 13.25% |
| 2022-09-30 | $0.02B | $0.12B | 14.40% |
| 2022-06-30 | $0.02B | $0.12B | 15.97% |
| 2022-03-31 | $0.02B | $0.13B | 17.27% |
| 2021-12-31 | $0.02B | $0.13B | 17.99% |
| 2021-09-30 | $0.01B | $0.09B | 12.62% |
| 2021-06-30 | $0.01B | $0.08B | 6.87% |
| 2021-03-31 | $0.01B | $0.07B | 8.20% |
| 2020-12-31 | $0.01B | $0.07B | 17.39% |
| 2020-09-30 | $0.01B | $0.07B | 24.54% |
| 2020-06-30 | $0.01B | $0.04B | 35.77% |
| 2020-03-31 | $0.01B | $0.03B | 37.04% |
| 2019-12-31 | $0.01B | $0.03B | 38.30% |
| 2019-09-30 | $0.01B | $0.03B | 42.35% |
| 2019-06-30 | $0.01B | $0.02B | 54.79% |
| 2019-03-31 | $0.01B | $0.02B | 64.52% |
| 2018-12-31 | $0.01B | $0.02B | 76.92% |
| 2018-09-30 | $0.01B | $0.01B | 95.24% |
| 2018-06-30 | $0.01B | $0.01B | 102.86% |
| 2018-03-31 | $0.01B | $0.01B | 128.57% |
| 2017-12-31 | $0.01B | $0.01B | 121.74% |
| 2017-09-30 | $0.00B | $0.01B | 88.89% |
| 2017-06-30 | $0.00B | $0.00B | 70.59% |
| 2017-03-31 | $0.00B | $0.00B | 23.53% |
| 2016-12-31 | $0.00B | $0.00B | 23.53% |
| 2016-09-30 | $0.00B | $0.01B | 0.00% |
| 2016-06-30 | $-0.00B | $0.00B | -23.53% |
| 2016-03-31 | $-0.00B | $0.00B | -22.22% |
| 2015-12-31 | $-0.00B | $0.00B | -40.00% |
| 2015-09-30 | $0.00B | $0.01B | 0.00% |
| 2015-06-30 | $0.00B | $0.01B | 0.00% |
| 2015-03-31 | $-0.01B | $0.01B | -70.59% |
| 2014-12-31 | $-0.01B | $0.01B | -54.55% |
| 2014-09-30 | $-0.01B | $0.01B | -88.89% |
| 2014-06-30 | $-0.01B | $0.01B | -77.61% |
| 2014-03-31 | $-0.01B | $0.02B | -45.00% |
| 2013-12-31 | $-0.01B | $0.02B | -35.96% |
| 2013-09-30 | $-0.00B | $0.02B | -12.24% |
| 2013-06-30 | $-0.00B | $0.02B | -7.92% |
| 2013-03-31 | $0.00B | $0.03B | 0.00% |
| 2012-12-31 | $0.00B | $0.03B | 0.00% |
| 2012-09-30 | $0.00B | $0.03B | 4.12% |
| 2012-06-30 | $0.00B | $0.03B | 8.70% |
| 2012-03-31 | $0.00B | $0.02B | 9.30% |
| 2011-12-31 | $0.00B | $0.02B | 10.13% |
| 2011-09-30 | $0.00B | $0.02B | 5.48% |
| 2011-06-30 | $0.00B | $0.02B | 0.00% |
| 2011-03-31 | $0.00B | $0.02B | 0.00% |
| 2010-12-31 | $0.00B | $0.02B | 0.00% |
| 2010-09-30 | $0.00B | $0.02B | 0.00% |
| 2010-06-30 | $0.00B | $0.01B | 0.00% |
| 2010-03-31 | $0.00B | $0.01B | 8.00% |
| 2009-12-31 | $0.00B | $0.01B | 16.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.236B | $0.184B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.977B | 28.52 |
| Boston Scientific (BSX) | United States | $155.488B | 41.98 |
| Stryker (SYK) | United States | $147.446B | 31.70 |
| EssilorLuxottica (ESLOY) | France | $140.780B | 0.00 |
| Medtronic (MDT) | Ireland | $112.764B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.084B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.818B | 29.12 |
| GE HealthCare Technologies (GEHC) | United States | $42.113B | 20.51 |
| Agilent Technologies (A) | United States | $39.025B | 25.86 |
| ResMed (RMD) | United States | $34.189B | 26.33 |
| Terumo (TRUMY) | Japan | $26.310B | 37.41 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.630B | 12.95 |
| Insulet (PODD) | United States | $20.222B | 86.57 |
| Baxter (BAX) | United States | $17.074B | 12.34 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.245B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.513B | 35.65 |
| Bio-Rad Laboratories (BIO) | United States | $8.001B | 27.70 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 13.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.200B | 20.05 |
| ICU Medical (ICUI) | United States | $3.995B | 38.03 |
| Envista Holdings (NVST) | United States | $3.693B | 29.38 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.188B | 15.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.921B | 19.69 |
| QuidelOrtho (QDEL) | United States | $2.760B | 23.18 |
| LeMaitre Vascular (LMAT) | United States | $2.269B | 55.15 |
| Neogen (NEOG) | United States | $2.178B | 25.10 |
| AtriCure (ATRC) | United States | $1.914B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.90 |
| InMode (INMD) | Israel | $1.320B | 11.03 |
| BioLife Solutions (BLFS) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.180B | 8.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.997B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.938B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.930B | 14.27 |
| Evolus (EOLS) | United States | $0.926B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.689B | 0.00 |
| Valneva SE (VALN) | France | $0.643B | 0.00 |
| Omeros (OMER) | United States | $0.557B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.494B | 3.86 |
| Surmodics (SRDX) | United States | $0.492B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.321B | 58.60 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.52 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Biote (BTMD) | United States | $0.260B | 5.69 |
| Canopy Growth (CGC) | Canada | $0.250B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| Brainsway (BWAY) | Israel | $0.212B | 112.80 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.39 |
| MacroGenics (MGNX) | United States | $0.181B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 12.79 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| InterCure (INCR) | Israel | $0.075B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Exagen (XGN) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.058B | 30.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| MariMed (MRMD) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.22 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| INLIF (INLF) | $0.040B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |